Open Access<p>Increased Expression of TAP Is Predictive of Poor Prognosis in Patients with Non-Small Cell Lung Cancer</p>
Author(s) -
Yuanjun Cheng,
Yongbing Chen,
Guohui Zang,
Bin Chen,
Jie Yao,
Wenguang Zhang,
Haibing Wang,
Li Yu,
Pinghai He,
Youming Zhang,
Hongyan Wu
Publication year - 2020
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s239593
Subject(s) - medicine , lung cancer , oncology , metastasis , tap water , cancer , colorectal cancer , lung , environmental engineering , engineering
The most common cancer among humans is lung cancer. Non-small cell lung cancer (NSCLC) comprises the majority of these cases. In the development and progression of cancers across the spectrum, tumor abnormal protein (TAP) plays crucial roles. Additionally, in the advancement of the bladder and colorectal cancers, the involvement of glycoproteins like TAP is present. However, it is worth noting that current literature has yet to clarify the clinical significance of the TAP in NSCLC.